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Background: Hypothyroidism, the most common endocrine disease, induces cardiac electrical remodeling that
creates a substrate for ventricular arrhythmias. Recent studies report that high thyrotropin (TSH) levels are
related to cardiac electrical abnormalities and increased mortality rates. The aim of the present work was to
investigate the direct effects of TSH on the heart and its possible causative role in the increased incidence of
arrhythmia in hypothyroidism.
Methods: A new rat model of central hypothyroidism (low TSH levels) was created and characterized together
with the classical propylthiouracil-induced primary hypothyroidism model (high TSH levels). Electro-
cardiograms were recorded in vivo, and ionic currents were recorded from isolated ventricular myocytes in vitro
by the patch-clamp technique. Protein and mRNA were measured by Western blot and quantitative reverse
transcription polymerase chain reaction in rat and human cardiac myocytes. Adult human action potentials were
simulated in silico to incorporate the experimentally observed changes.
Results: Both primary and central hypothyroidism models increased the L-type Ca2+ current (ICa-L) and de-
creased the ultra-rapid delayed rectifier K+ current (IKur) densities. However, only primary but not central
hypothyroidism showed electrocardiographic repolarization abnormalities and increased ventricular arrhythmia
incidence during caffeine/dobutamine challenge. These changes were paralleled by a decrease in the density of
the transient outward K+ current (Ito) in cardiomyocytes from animals with primary but not central hypothy-
roidism. In vitro treatment with TSH for 24 hours enhanced isoproterenol-induced spontaneous activity in
control ventricular cells and diminished Ito density in cardiomyocytes from control and central but not primary
hypothyroidism animals. In human myocytes, TSH decreased the expression of KCND3 and KCNQ1, Ito, and
the delayed rectifier K+ current (IKs) encoding proteins in a protein kinase A–dependent way. Transposing the
changes produced by hypothyroidism and TSH to a computer model of human ventricular action potential
resulted in enhanced occurrence of early afterdepolarizations and arrhythmia mostly in primary hypothyroid-
ism, especially under b-adrenergic stimulation.
Conclusions: The results suggest that suppression of repolarizing K+ currents by TSH underlies most of the
electrical remodeling observed in hypothyroidism. This work demonstrates that the activation of the TSH-
receptor/protein kinase A pathway in the heart is responsible for the cardiac electrical remodeling and ar-
rhythmia generation seen in hypothyroidism.
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Introduction
Recent studies highlight the importance of thyrotro-pin (TSH) levels in the mortality of both hypothyroid
and euthyroid individuals. Patients with treated overt hypo-
thyroidism with serum TSH levels between 0.5 and 5 mIU/L
have significantly lower mortality rates than patients with
TSH levels between 5 and 10 mIU/L (1). Moreover, a recent
study demonstrated that high-normal TSH levels are associ-
ated with higher mortality than mid-normal levels in non-
hypothyroid individuals (2), but the mechanisms responsible
for this elevated mortality are unknown.
In this context, it has been reported that hypothyroid pa-
tients show electrocardiogram (ECG) abnormalities such as
atrial fibrillation, prolonged QT and QTc intervals, and
greater QT dispersion. This electrical remodeling creates a
pro-arrhythmic substrate and facilitates the occurrence of
ventricular arrhythmias including torsades de pointes (3–7).
Surprisingly, patients with subclinical hypothyroidism, with
normal triiodothyronine (T3)/thyroxine (T4) levels but ele-
vated TSH, show similar repolarization alterations in the
ECG as those with overt hypothyroidism (5,7), suggesting the
involvement of TSH in cardiac electrical remodeling and
arrhythmia. In the last decade, clinical observations have
shown a direct correlation between serum TSH levels and
QT/QTc prolongation in hypothyroid patients (4,5,7–9). In
agreement with this hypothesis, it was recently reported that
in vitro treatment of healthy cardiac myocytes with TSH
decreases the amplitude of different repolarizing K+ currents
and the expression of their channel proteins (10).
This study used animal models of primary (high TSH) and
central (low TSH) hypothyroidism, as well as adult human
atrial myocytes and computational modeling, to gain insight
into the mechanisms underlying myocardial electrical re-
modeling by TSH. The results presented here suggest that the
cardiac electrical remodeling and enhanced arrhythmia sus-
ceptibility in primary hypothyroidism under adrenergic stim-
ulation are due to: (i) an increase of the depolarizing inward
calcium current secondary to the reduction of thyroid hormone
levels; (ii) a TSH receptor/protein kinase A (PKA)-dependent
reduction of the expression of the pore-forming proteins of the
channels that carry the repolarizingoutward potassiumcurrents
Ito and IKs; and (iii) the appearance of early afterdepolarizations
(EAD) and arrhythmias secondary to prolongation of repolar-
ization, especially under b-adrenergic stimulation. In sum-
mary, this work demonstrates the direct involvement of TSH in
the cardiac electrical remodelingand arrhythmiapredisposition
seen in hypothyroidism.
Methods
Animals and induction of hypothyroidism
The investigation fulfilled the Spanish (RD 1201/2005),
Brazilian (Federal Law 11794), and European (D2003/65/CE
and R2007/526/CE) rules for animal care used for experi-
mental and other research purposes, and has been approved
by the Ethics Committee for Animal Care of the Universidad
del Paı´s Vasco (CEBA/46/2010) and the Ethics Committee
for Animal Care and Use of the University of Campinas
(CEUA/B/UNICAMP, Brazil, No. 4429-1).
Hypothyroidism was induced in Sprague Dawley rats
(200 g). Primary hypothyroidism was induced by the addition
of 0.02% propylthiouracil (PTU; Sigma–Aldrich) to the
drinking water for six weeks, which is a widely used, well
characterized animal model of primary hypothyroidism. For
induction of central hypothyroidism, animals were treated by
daily gavage with bexarotene (BXT) for six weeks at a dose
of 50mg/kg, which was the lowest tested dose that induced
hypothyroidism in 100% of the animals in preliminary ex-
periments. Previous tests also showed an absence of differ-
ences between rats receiving daily gavage with dimethyl
sulfoxide, which was used to dissolve BXT, and non-treated
controls.
Animals were weighed weekly, and body temperature was
taken as that measured from the outer ear with an infrared
thermometer. Blood samples were collected from the tail vein
under light anesthesia (with isofluorane), and hormone levels
were determined with T4 and TSH enzyme-linked immu-
nosorbent assay kits (Diametra and Demeditec Diagnosis
Gmbh, respectively) following the manufacturers’ instruc-
tions. After six weeks, the animals were killed by heart re-
moval under deep anesthesia with ketamine and xylazine
(50mg/kg and 1.5mg/kg, respectively, administered intra-
peritoneally [i.p.]). The thyroid glands were removed and
immersed in 4% paraformaldehyde. After fixation, 30 lm
sections were stained with hematoxylin and eosin.
In vivo electrophysiological experiments
ECG recording was carried out in conscious animals with
permanent surgical steel electrodes inserted under anesthesia,
positioned in the DII lead, and connected by flexible cables to
a differential amplifier MP35 (Biopac Systems, Inc.). The
signal was filtered at 100Hz and digitized at 1 kHz using BSL
Pro v3.7 (Biopac Systems, Inc.). The measurements were
performed blinded to the experimental groups. The QT in-
terval was measured from the beginning of the QRS complex
to the end of the T wave and was corrected for the heart rate
using the Bazzet formula, QTc =QT/OR-R.
At the end of the six-week experimental period, the ar-
rhythmia vulnerability test was performed in control and
hypothyroid rats under isoflurane anesthesia. A baseline ECG
was recorded for three minutes, and then rats were injected
with caffeine (120mg/kg i.p.) and dobutamine (50lg/kg
administered intravenously). The ECG was then recorded for
10 minutes, and the incidence of arrhythmias was quantified.
Ventricular myocyte isolation
Cardiac myocytes were isolated in a Langendorff appara-
tus, as previously described (10,11). The hearts were moun-
ted through the aorta on a Langendorff apparatus and
perfused retrogradely with Tyrode solution containing (in
mmol/L): NaCl 118, KCl 5.4, NaHCO3 24, MgCl21.02,
CaCl2 1.8, NaH2PO4 0.42, dextrose 12, and taurine 20,
bubbled with 95%O2 and 5% CO2, pH 7.4, at 37C, followed
by perfusion with the same solution without Ca2+ to which
collagenase type II (0.5mg/mL) and protease type XIV
(0.03mg/mL) were added later. Hearts were finally perfused
with KB solution (in mmol/L): taurine 10, glutamic acid 70,
creatine 0.5, succinic acid 5, dextrose 10, KH2PO4 10, KCl
20, HEPES-K+ 10, EGTA-K+ 0.2, pH adjusted to 7.4 with
KOH. Then, the ventricular cardiomyocytes were dissociated
by mechanical agitation. When isolated for cardiac calcium
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handling experiments, EGTA was not included in the KB
solution.
In vitro electrophysiology patch-clamp experiments
All experiments were performed at room temperature (20–
22C). Following the patch rupture, the whole-cell membrane
capacitance was measured by integration of the capacitive
transients elicited by voltage steps from -50 to -60mV.
Series resistance was compensated 80% in order to minimize
voltage errors.
Ionic currents were recorded using the whole-cell config-
uration with an Axopatch 200B patch-clamp amplifier
(Molecular Devices). Recording pipettes pulled from boro-
silicate tubes (Sutter Instruments) had a tip resistance of
1–3MO when filled with the internal solution. The pipette
solution used for Ito and ICa-L recording was (in mmol/L): L-
aspartic acid (potassium salt) 80, KH2PO4 10, MgSO4 1, KCl
50, HEPES-K+ 5, ATP-Na2 3, EGTA
-K+ 10, pH adjusted to
7.2 with KOH. For the current carried by NCX (INCX), the
internal solution was: CsCl 115, NaCl 10, TEA-Cl 10, Mg-
ATP 5,MgCl2 0.5, HEPES 10, pH adjusted to 7.2 with CsOH.
For Ito recording, the bath solution was (in mmol/L): NaCl
86, MgCl2 1, HEPES
-Na+ 10, KCl 4, CaCl2 0.5, CoCl2 2,
dextrose 11, TEA-Cl 50, pH adjusted to 7.4 with NaOH. For
ICa-L, the solution composition was (in mmol/L): NaCl 86,
MgCl2 1, HEPES
-Na+ 10, KCl 4, CaCl21.8, TEA-Cl 50, 4-
aminoprirydine 4, dextrose 11, pH adjusted to 7.4 with
NaOH. Voltage pulses (500ms long) to a test potential
ranging from -30 to +50mV, starting from a holding po-
tential of -60mV, were applied at a frequency of 0.1Hz to
ensure the full channel recovery from inactivation, whereas
for ICa-L recording, the 500ms test pulses were preceded by a
40ms pre-pulse to -40mV.
For recording INCX, the external solution was (in mmol/L):
CsCl 10, NaCl 130, MgCl2 0.5, CaCl2 1, HEPES 10, dextrose
10, pH adjusted to 7.4 with NaOH. The current was recorded
during application of a ramp from +80 to -140mV following
a 150ms step to +80mV, from a holding potential of -90mV,
after sequential pre-pulses to -45 and 0mV to inactivate Na+
and Ca2+ channels, respectively. The protocol was repeated
in the presence of 10mM NiCl2 to inhibit NCX. INCX was
considered as the difference of the currents recorded in the
absence and presence of Ni2+.
The voltage-clamp experimental protocols were controlled
with the ‘‘Clampex’’ program, and current recordings were
analyzed with the ‘‘Clampfit’’ program of the pClamp10.2
software (Molecular Devices). Current amplitudes were
normalized to cell capacitance and expressed as pA/pF.
Measurement of [Ca2+]i
After 24 hours of incubation at 4C with EGTA-free KB
solution with or without 30 mIU/L TSH, [Ca2+]i was mea-
sured in rat myocytes loaded with indo-1 AM (Molecular
Probes) for 15 minutes followed by 30 minutes of washout.
Cells were perfused at 22–24C with Tyrode’s solution
containing 1mmol/L CaCl2. The fluorescence emission ratio
at 410 and 485 nm under 360 nm excitation was converted to
[Ca2+]I, as described elsewhere (11). Ca
2+ transients were
recorded after interruption of 1Hz electrical stimulation
followed by switching perfusion to normal or Na+, Ca2+-free
Tyrode solution containing 10mmol/L caffeine. The rate
constant of [Ca2+]i decline (K) was determined by nonlinear
curve fit. Sustained activation of sarcoplasmic reticulum (SR)
Ca2+ release channels by caffeine prevents net Ca2+ accu-
mulation in the organelle, so that most of [Ca2+]i decline
should be carried by the NCX, if the external solution con-
tains Na+, whereas the exchanger is thermodynamically in-
hibited in Na+-free medium. Thus, the ratio of K determined
in the presence and absence of extracellular Na+ can be used
as an index of the NCX activity in the Ca2+ efflux mode (12).
The effect of b-adrenergic stimulation at inducing spon-
taneous activity was assessed by determination of concen-
tration–effect curves to isoproterenol (ISO), in which the rate
of spontaneous Ca2+ transients was measured after interrup-
tion of electrical stimulation.
Quantitative real-time polymerase chain reaction
This study conforms to the principles outlined in the De-
claration of Helsinki and was approved by the Ethics Com-
mittee of the Instituto Nacional de Cardiologia (CEP-0358/
07-11-2011). Human right atrial samples were obtained from
patients in sinus rhythm who underwent cardiac surgery
(n = 8). Clinical data of the patients are included in Supple-
mentary Table S1.
Just after excision, each sample was cut in pieces that were
incubated for 24hours at 4C in the absenceor in thepresenceof
TSH, either with or without of 5lmol/L of the PKA blocker
H89, afterwhich the levels ofmRNAexpression of theKCND3,
KCNQ1, and KCNH2 genes were measured by quantitative
reverse transcriptionpolymerasechain reaction.TotalRNAwas
extracted from 10mg of frozen tissue treated with DNase using
the RNeasy Fibrous Tissue Mini Kit (Qiagen) following the
manufacturer’s instructions. The concentration of total RNA in
each sample was measured spectrophotometrically using Na-
noDrop 2000 (Thermo Fisher Scientific). Next, 1lg of total
RNA was reversely transcribed into cDNA using random
primers and the High Capacity Reverse Transcription Kit
(Applied Biosystems). The reactions were carried out in the
PTC-100 Programmable Thermal Controller (MJ Research).
The program was 25C for 10 minutes, 37C for 120 minutes,
85C for 5 minutes, and 4C for 10 minutes.
Determinations were performed on 96-well plates in 15lL
final volume containing 2lL of 10· diluted KCND3,
KCNH2, and KCNQ1 cDNA stock, 7.5 lL of Power SYBR
Master Mix (Applied Biosystems), and 150mmol/L of each
forward and reverse of KCND3, KCNH2, and KCNQ1
primers (see Supplementary Table S2). The amplification
program was 55C for 2 minutes, 95C for 10 minutes, fol-
lowed by 40 cycles of 95C for 30 seconds and 60C for 1
minute. Each cDNA in duplicate and a corresponding sample
without reverse transcriptase were included as a negative
control. The mRNA expression of the chosen genes was
normalized to that ofGAPDH used as an internal control. The
relative quantities of gene-specific mRNA were determined
by the comparative Ct method, by which the relative gene
expression in the TSH-treated group is expressed by the
formula 2(DDCt), where Ct refers to the ‘‘threshold cycle’’
determined for each plate by the ViiA 7 Real-Time PCR
System (Applied Biosystems); DCt is the difference between
the Ct values of the target mRNA and that of GAPDH; and
DDCt is the difference between the mean DCt of the TSH and
control groups. The fold-change in the expression of the
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target genes was calculated as the mean – standard deviation
of 2(DDCt) for the control and TSH groups.
Computational modeling
Human ventricular action potentials (AP) of 550 control
individuals in resting conditions and under b-adrenergic
stimulation were simulated using the O’Hara–Rudy dynamic
(ORd) model (13) as baseline. Following the methodology by
Passini et al. (14), ionic conductances were set at 20–200% of
the baseline values of the ORd ‘‘average human’’ to include
ion current profiles with variable channel densities while
keeping the AP parameters (peak voltage, maximum upstroke
velocity, resting membrane potential, AP duration at 50% and
90% repolarization, and triangulation) within the normal
range. The main ionic conductances considered were: fast and
late Na+ currents (GNa and GNaL, respectively), Ito (Gto), IKr
and IKs (GKr and GKs), inward rectified K
+ current (GK1), INCX
(GNCX), Na
+/K+ pump (GNaK), and ICa-L (GCa-L). All simula-
tions presented in this study were conducted using Virtual
Assay (ª 2016, University of Oxford; v.1.3.640 2014; Oxford
University Innovation Ltd.), a software package for in silico
drug assays, kindly provided by B. Rodrı´guez.
In order to reproduce the hypothyroid phenotype in this
population of 550 AP models, ionic conductances were mod-
ified according to the experimental findings in both a past study
(10) and the present study. To simulate the change in ICa-L in
both types of hypothyroidism, GCa-L was augmented by 55%.
To simulate the changes associated with primary hypothy-
roidism, Gto and GK1 were reduced to 50% of control, whereas
GKs and GNCX were reduced to 60% and 70% of control, re-
spectively. In the simulations, trains of 500 APwere evoked at
1Hz, and the last AP trace in each simulation was presented.
Simulations of the impact of the ion current changes ob-
served in hypothyroidism were also performed on the
Nygren–Firek–Clark–Lindblad–Clark–Giles model (15) of
human atrial AP. The simulations presented in this study
were conducted with permission using The Virtual Heart
Web page by Flavio Fenton (16–18), and are described in the
Supplementary Methods.
Statistical analysis
Data are presented as means – standard error of the mean.
Data were compared with Student’s t-test or analysis of
variance followed by Bonferroni’s t-test. Arrhythmia inci-
dence was evaluated with a contingency table and Pearson’s
chi-square test. A p-value of <0.05 was considered as sta-
tistically significant.
Results
Animal models
Although PTU treatment is a widely used procedure for
induction of primary hypothyroidism, to the best of the au-
thors’ knowledge, an animal model of central hypothyroid-
ism had not yet been developed. The anticancer drug BXT
exerts a direct inhibitory effect on the TSH-producing cells of
the pituitary gland (19,20). Advantage was taken of this un-
wanted side effect to create a central hypothyroidism ex-
perimental model, which was tested in this study.
Both PTU and BXT treatments reduced blood T4 concen-
tration within one week, attaining almost undetectable levels
after two weeks (Fig. 1A). Since PTU directly induces mal-
function of the thyroid gland, bloodTSHconcentration showed
a 10-fold increase, reaching its maximum at week 4. BXT, on
FIG. 1. Characterization of
the hypothyroidism animal
models. (A) Free thyroxine
(T4) blood levels are almost
undetectable after two weeks
of either primary or central
hypothyroidism. (B) Serum
thyrotropin (TSH) levels
were increased more than 10-
fold in primary hypothyroid-
ism but were undetectable in
animals with central hypo-
thyroidism. (C) Thyroid
gland weight showed oppo-
site changes in primary and
central hypothyroidism after
six weeks of induction. (D)
Hematoxylin and eosin
stained sections of the thy-
roid gland six weeks after
induction of primary (pHT)
and central hypothyroidism
(cHT) also show opposite
structural modifications.
Scale bars indicate 200 lm
and 100· lm at 20 · and
40· , respectively. n = 18
control, 15 pHT, and 17 cHT
animals. Means – standard
error of the mean (SEM).
*p < 0.05; **p < 0.01.
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the other hand, is expected to reduce T4 levels due to its toxic
effect on the pituitary gland. Accordingly, TSH levels were
reduced, reaching the minimum at week 4 (Fig. 1B).
After six weeks of primary hypothyroidism, the high circu-
lating TSH levels induced thyroid growth with an increase in
epithelial cell height, whereas in low TSH central hypothy-
roidism, gland size and follicular cells height were slightly re-
duced (Fig. 1C and D and Supplementary Fig. 1A). Primary
hypothyroidism reduced body weight, which was not changed
in control or centrally hypothyroid animals. Neither body
temperature nor relative heart mass was significantly different
among the three groups of animals (Supplementary Fig. 1B–D).
Electrocardiographic characteristics
As previously published (21), primary hypothyroidism
reduced heart rate compared to control animals, whereas a
less pronounced effect was seen in the centrally hypothyroid
group (Fig. 2A and B). Similarly to patients with primary
hypothyroidism (5), the primary hypothyroidism group
showed repolarization abnormalities, such as prolongation of
the QT, QTc, and Tpeak-to-Tend intervals. However, none of
these alterations was present in centrally hypothyroid animals
(Fig. 2B).
The ECG alterations seen in hypothyroid animals may
represent a substrate for the development of cardiac ar-
rhythmias. Thus, the animals were subjected to an arrhythmia
vulnerability test under acute challenge with caffeine and
dobutamine. The incidence of cardiac arrhythmias was in-
creased twofold in animals with primary hypothyroidism,
while only a nonsignificant trend of increase was seen in the
centrally hypothyroid group (Fig. 2C).
Cardiac electrical remodeling
The amplitude of ICa-L in ventricular myocytes increased
in both primary and central hypothyroidism when compared
to the control group (Fig. 3A and B). These results support the
reported absence of effect of TSH on this current (10) and the
suppressive effect of thyroid hormones on L-type Ca2+
channels, since T3/T4 deficiency increases both calcium
channel expression and current amplitude (22,23).
In ventricular myocytes isolated from animals with pri-
mary hypothyroidism, the Ito amplitude was reduced, but it
was not affected by central hypothyroidism (Fig. 3C and D).
In addition, hypothyroidism modified neither the voltage-
dependence of the steady-state inactivation of the current nor
the time-dependence of recovery from inactivation (Supple-
mentary Fig. 2A and B). Thus, although primary hypothy-
roidism reduced Ito density, the biophysical properties of the
channel were not modified, suggesting a reduction of the
channel abundance. Accordingly, expression of the Kv4.2
and Kv4.3 channel proteins was significantly reduced in
ventricles from rats with primary hypothyroidism, but it was
conserved in hypothyroidism of central origin (Supplemen-
tary Fig. 2C). Thus, the absence of thyroid hormones does not
seem to be the mechanism responsible for the reduction in Ito
density and channel expression in rats with primary hypo-
thyroidism, pointing to high TSH levels as the likely factor
involved in these changes.
Although its physiological relevance is lower than Ito, the
ultra-rapid delayed rectifier K+ current IKur is also present in
the rat ventricle. In ventricular myocytes, the IKur amplitude
was similarly decreased in both primary and central hypo-
thyroidism when compared to the control group (Supple-
mentary Fig. 3A and B). As for ICa-L, these results support a
direct role of thyroid hormones and lack of influence of TSH
on this current, as previously reported (10).
Role of TSH in electrical remodeling
Next, the study explored at the cellular level a possible
direct role of TSH in the electrophysiological changes seen in
animal models of hypothyroidism. Isolated ventricular
myocytes were incubated for 24 hours in medium containing
30mIU/L of TSH, a concentration commonly seen in primary
hypothyroid patients. As shown in Figure 4A, TSH had no
effect on ICa-L either in control or in the hypothyroid groups.
On the other hand, incubation with TSH differentially
modulated the Ito amplitude in the three experimental groups.
While exposure to TSH significantly reduced the Ito ampli-
tude in myocytes from control and centrally hypothyroid rats
(Fig. 4B), exogenous TSH had no effect on Ito density in
myocytes from animals with primary hypothyroidism, a
model with high circulating TSH levels in which Ito was
already decreased (Fig. 4B).
TSH effect on cardiomyocyte Ca2+ handling
NCX has been implicated in the development of Ca2+-
dependent spontaneous electrical activity in myocardial cells
(24,25). Incubation of control myocytes with TSH for
24 hours did not cause apparent cellular Ca2+ overload.
However, TSH exposure significantly prolonged the decay
phase of Ca2+ transients generated by caffeine-induced mas-
sive SR Ca2+ release, which relies mainly on NCX (Fig. 5A,
left). The decrease in the ratio of the time constants for decline
of the cytosolic Ca2+ concentration of caffeine-evoked tran-
sients in the presence and absence of Na+ after TSH incuba-
tion (Fig. 5A, right) confirmed that the hormone depressed the
Na+-dependent Ca2+ efflux. Accordingly, the INCX amplitude
was smaller ( p< 0.001) in cells preincubated with TSH, over
the whole tested voltage range (Fig. 5B). Nevertheless, TSH
treatment caused a leftward shift in the current reversal po-
tential from -17.4 – 4.9 to -46.5 – 6.4mV ( p < 0.01).
Finally, the effect of TSH incubation on the development
of spontaneous contractions after interruption of electrical
stimulation was tested in the absence and presence of the
b-adrenoceptor agonist ISO. In the absence of the agonist,
TSH-treated cells showed greater incidence of spontaneous
activity after a brief (10 seconds) train of stimulation at all
tested rates, from 0.5 to 2Hz (Fig. 5C, left). Another stimu-
lation protocol (1Hz for 2 minutes) (26) was used to test
b-adrenergic stimulation with ISO. Although ISO was ef-
fective at inducing automatism in cells incubated with and
without TSH ( p < 0.001), the response was more prominent
in the latter group ( p < 0.05 for treatment · [ISO] interac-
tion), in which the maximum rate of spontaneous events was
twofold greater (Fig. 5C, right).
Effects of TSH on human cardiac myocytes
Next, the study explored whether the effects of TSH on
cardiac electrical properties observed in rodents also occurred
in human cardiomyocytes. Thus, the study tested whether TSH
incubation for 24 hours affects the expression of the channels
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FIG. 2. Electrocardiographic (ECG) characteristics of central and primary hypothyroidism. (A) ECG recordings before
(W0) and after six weeks of hypothyroidism (W6). The dotted lines delineate the QT interval. (B) Both central and primary
HT prolonged the R-R interval. Only primary HT prolonged the QTc, PR and QT intervals, and Tpeak-to-Tend duration.
QRS complex duration was not modified in any HT model (n = 18, 13, and 17 animals/group, respectively). (C) After
caffeine/dobutamine challenge, the incidence of ventricular arrhythmias was increased twofold only in the primary hy-
pothyroid group compared to control animals. The numbers in the columns are arrhythmic animals/total animals in the
group. Data were compared with analysis of variance followed by Bonferroni’s t-test. Means – SEM. *p < 0.05; **p < 0.01.
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that carry repolarizing K+ currents in adult human myocytes.
TSH reduced the expression of theKCND3 andKCNQ1 genes,
which might result in a reduction of Ito and IKs, as seen in
rodents in both prior studies (10,22) and in the present study.
TSH, however, did not affect the expression of KCNH2, re-
sponsible for the IKr current in human heart (Fig. 6A).
Next, the study explored the molecular mechanism in-
volved in the effect of TSH on K+ channel expression in the
heart. The TSH receptor is canonically coupled to a Gsa
protein and activates the adenylyl cyclase/PKA pathway. To
test the effect of PKA inhibition, samples were treated with
TSH for 24 hours in the presence of H89, which fully elim-
inated the effect of TSH on the expression of the studied
channels (Fig. 6A).
Computer simulation of human AP
A population of 550 human ventricular AP profiles was
simulated with different ion channel densities, by sampling
the main ventricular ionic conductances in the 20–200%
range of the averaged values in the ORd model (13), either
under resting conditions or after b-adrenergic stimulation
(Fig. 6B). When ionic conductances were changed to simu-
late the alterations seen in the primary hypothyroid condi-
tions (see Methods), 24/550 models showed EAD and
arrhythmias under resting conditions, and the incidence in-
creased to 33/550 after b-adrenergic stimulation. When ionic
conductances were adjusted to simulate central hypothy-
roidism, EAD was not observed under resting conditions, but
after b-adrenergic stimulation, EADs and arrhythmias were
generated in 26/550 cases.
The same kind of simulation carried out with the Nygren–
Firek–Clark–Lindblad–Clark–Giles model (15) of atrial AP
reproduced the results obtained with the ventricular model:
arrhythmias appeared in the primary hypothyroidism model,
whereas only isolated EADs were seen in the central hypo-
thyroidism model (Supplementary Fig. S4).
Discussion
For decades, PTU-induced hypothyroidism has been the
most widely used animal model (21,27). After PTU
FIG. 3. Hypothyroidism differ-
ently modulated Ca2+ and K+ cur-
rents. (A) ICa-L traces recorded in
ventricular myocytes isolated from
control animals and from animals
with primary and central hypothy-
roidism. Dashed lines represent the
0 current level. (B) Current–voltage
relationship and maximum ICa-L
amplitude at +10mV showing a
similar increase in ICa-L density in
both central and primary hypothy-
roidism (n = 8–15 cells from at least
three animals in each group;
*p < 0.05). (C) Traces of Ito re-
corded in ventricular myocytes
isolated from control animals and
from animals with primary and
central hypothyroidism. Dashed
lines represent the 0 current level.
(D) Current–voltage relationships
and maximum Ito amplitude at
+50mV, showing that primary hy-
pothyroidism reduced Ito density,
whereas hypothyroidism of central
origin had no effect on this current
(n = 10–15 cells from at least three
animals in each group; *p < 0.05).
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treatment, T4 becomes undetectable, and TSH increases
more than 10-fold. However, to the best of the authors’
knowledge, a well-characterized animal model of central
hypothyroidism has been lacking. The rexinoid drug BXT
(28,29) induces reversible central hypothyroidism in both
patients and experimental animals (19,20). In the present
work, both T4 and TSH levels were very significantly re-
duced after BXT treatment, resulting in a sustained hypo-
thyroid status. In conclusion, BXT treatment (50mg/kg by
daily gavage) generates a new and reliable animal model of
central hypothyroidism.
It is well known that secondary hypothyroidism does not
produce the same clinical and biochemical degree of hypo-
thyroidism as primary thyroid underfunction. In addition,
secondary hypothyroidism is usually a part of a more complex
phenotype, with anterior pituitary insufficiency or pan-
hypopituitarism caused by entities such as pituitary/hypotha-
lamic neoplasia or infiltration, surgery, or irradiation (3,30).
However, the severity of hypothyroidism found in the PTU and
BXT animal models used in this study is similar, since T4 is
undetectable in both. Many (probably most) cardiac and sys-
temic manifestations of primary hypothyroidism are directly
related to the lack of thyroid hormones. However, the novelty
of the study presented here is to present data that demonstrate
that a subset of the cardiac electrical remodeling is associated
with the high TSH levels found in primary hypothyroidism.
FIG. 4. TSH modulation of Ca2+ and K+ currents in myocytes from control animals and rats with either central or primary
hypothyroidism. (A) Incubation for 24 hours with 30 mIU/L of TSH did not affect ICa-L in any of the experimental groups
(n = 8–9 cells from three different animals in each group). (B) Incubation with TSH reduced the Ito amplitude in the control
and central hypothyroid groups, but had no effect in the primary hypothyroidism group. Means – SEM. n = 10–13 cells from
at least three different animals in each group. Dashed lines represent the 0 current level. *p < 0.05; **p < 0.01.
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The prolongation of the QTc interval seen in ECGs of
hypothyroid patients was reproduced in animals with primary
hypothyroidism but not in the central hypothyroid model,
which suggests that it is not solely dependent on thyroid
hormone deficiency. In addition, the incidence of arrhythmias
in rats with primary hypothyroidismwas twofold elevated but
not observed in animals with central hypothyroidism. Thus,
we conclude that hypothyroidism-induced increase of the
ventricular vulnerability to arrhythmia is associated with the
high serum TSH levels.
Thyroid hormones inhibit the expression of L-type Ca2+
channels (23), and therefore, in primary hypothyroidism,
CaCN1C gene expression increases (22). Accordingly, the
present results show an increase of the ICa-L amplitude in the
two models of hypothyroidism, supporting the causative role
of the decreased levels of thyroid hormones. On the other
hand, it was also observed that IKur was reduced in both
hypothyroid models, as in previous studies (22,31). This in-
dicates that both the ICa,L and the IKur current are regulated by
thyroid hormones but not by TSH, as previously reported
(10). However, although the increase in ICa-L and the re-
duction in the IKur amplitude should contribute to prolonged
repolarization, this appears to occur only in primary but not in
central hypothyroidism, suggesting that there must be other
mechanisms involved in the ventricular electrical remodel-
ing. Nevertheless, these changes might, at least in part, ex-
plain the incidence of atrial arrhythmias in patients with
hypothyroidism.
A classical trigger of arrhythmias is the depolarizing cur-
rent carried by NCX, secondary to cellular Ca2+ overload
(24–26). However, the current results indicate that this is not
the trigger mechanism of the TSH-induced arrhythmogen-
esis. It was found that 24 hours of incubation of isolated
cardiac myocytes with TSH did not cause Ca2+ overload and
reduced the pro-arrhythmic INCX current. Conversely, during
b-adrenergic stimulation, the diastolic Ca2+ leak from the
sarcoplasmic reticulum is enhanced due to greater Ca2+ ac-
cumulation in the organelle (with contribution of ICa-L
stimulation, already augmented by hypothyroidism) and by
indirect stimulation of Ca2+ releasing channels (24,32). A
greater Ca2+ leak is expected to enhance INCX markedly be-
cause it increases the availability of subsarcolemmal Ca2+ to
be transported by the NCX. This, added to the prolonged
repolarization observed only after exposure to supranormal
TSH levels (TSH incubation and primary hypothyroidism), is
expected to promote pro-arrhythmic afterdepolarizations. It
should be noted that in animals with both primary hypothy-
roidism and TSH-treated isolated myocytes, enhanced
spontaneous/arrhythmic activity compared to controls was
seen under b-adrenergic stimulation. Beta-adrenergic stimu-
lation was also found to result in a marked increase in ven-
tricular pro-arrhythmic events in primary hypothyroidism.
FIG. 5. Effects of in vitro TSH
treatment on cardiomyocyte Ca2+
handling. (A) TSH increased the
half-time (t0.5) of [Ca
2+]i decay of
caffeine-evoked transients, which
depends mainly on NCX, and de-
creased the ratio of the rate con-
stants of [Ca2+]i decline of caffeine
transients in the presence (Kcaff)
and absence of Na+ (Kcaff-0Na;
n = 27 in control and 29 in the TSH
group). These results indicate a re-
duction of NCX activity in intact
myocytes. (B) Recordings of the
INCX in isolated ventricular myo-
cytes confirm the reduction of NCX
activity by TSH (n = 8 and 10 cells
for control and TSH groups, re-
spectively). (C) TSH increased the
number of spontaneous contrac-
tions (SC) during 200 seconds after
a 10-second stimulation train at
different frequencies (n = 18, 22,
16, 18, 11, and 9 for each column,
respectively). TSH treatment also
enhanced the concentration-
dependent induction of automatism
by isoproterenol (ISO) in rat ven-
tricular myocytes developed after
interruption of electrical stimula-
tion. n= 5 cells in each
group. Means –SEM. *p < 0.05.
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Overall, these findings indicate that that the electrical re-
modeling induced by TSH overexposure may sensitize the
myocardium to the pro-arrhythmic influence of adrenergic
stimulation, such as during exercise and under stressful
conditions.
Although thyroid hormones are necessary for the Ito de-
velopment in neonatal cardiac myocytes (33–35), it was
consistently observed that thyroid hormones have no effect
on Ito in cardiac myocytes from either euthyroid or hypo-
thyroid adult animals (35,36). Thus, while the increase in
ICa-L in hypothyroid animals can be explained by the de-
crease in thyroid hormones, this does not apply to the de-
crease of Ito. The present results suggest a direct action of
TSH as the mechanism responsible for the Ito reduction. In
accordance with this hypothesis and with previously pub-
lished data (10,21,22), ventricular Ito was reduced in the
high TSH model of primary hypothyroidism but not in the
low TSH central hypothyroid model. In addition, the in vitro
suppressive effect of TSH on Ito seen in myocytes from
controls could not be reproduced in cardiomyocytes isolated
from rats with primary hypothyroidism, in whom serum
TSH levels were elevated for six weeks and Ito was already
decreased. In contrast, incubation with TSH was able to
reduce Ito in cardiomyocytes from rats with central hypo-
thyroidism, in whom TSH levels were not elevated and the
Ito amplitude was not altered. All these results indicate a
central role of TSH in the cellular electrical remodeling in
primary hypothyroidism.
Although the prolongation of repolarization time seen in
rodents is mainly associated with Ito inhibition, in humans,
alterations of other K+ currents cannot be excluded. Thus, the
possible effects of TSH on human atrial samples were ex-
plored. TSH reduced the expression of the KCND3 and
KCNQ1 genes, which encode the channels that mediate Ito
and IKs respectively. This effect is likely to contribute to the
prolonged repolarization reported in patients with primary
hypothyroidism.
The presence of TSH receptors in the heart was previously
reported both at the mRNA and protein levels, and these
receptors appear to be functional and coupled to the adenylyl
cyclase-PKA pathway (37,38). The current and previously
reported results (10) demonstrate that either TSH receptor
blockade or PKA inhibition abolishes the effect of the hor-
mone on cardiac K+ channel expression, indicating that TSH
acts through its canonical pathway in the heart.
To translate to the human heart the experimental data on
susceptibility to triggered arrhythmia in hypothyroidism,
computer simulations of the electrophysiological behavior of
human cardiomyocytes were used. When the primary hypo-
thyroid phenotype was introduced in the models, EADs and
arrhythmias appeared, and their incidence increased after
b-adrenergic stimulation, consistent with the higher inci-
dence of arrhythmias in patients with primary hypothyroid-
ism (5) and with the current in vivo and in vitro experimental
results. It is also interesting to note that EADs and arrhyth-
mias emerged only under b-adrenergic stimulation in the
FIG. 6. Effects of TSH on human
cardiac myocytes in vitro and in
silico. (A) mRNA levels of KCNQ1
and KCND3 were reduced in TSH-
treated adult human atrial myocytes
when compared to control myo-
cytes, whereas KCNH2 expression
was not affected. The effect of TSH
was fully abolished by 5lM of the
PKA blocker H89. n = 8 hearts.
Means – SEM. *p < 0.05. (B)
Computational models were gen-
erated to simulate the action po-
tential of 550 control individuals in
resting conditions (upper panel)
and under b-adrenergic stimulation
(lower panel). Only 110 randomly
selected traces are shown for clar-
ity. When the ionic conductances
were changed to simulate the ef-
fects of primary hypothyroidism,
early afterdepolarization (EAD)
and arrhythmia appeared in resting
conditions and increased after beta-
adrenergic stimulation. When ionic
conductances were adjusted to
simulate central hypothyroidism,
EAD and arrhythmia were absent
in resting conditions but present
after b-adrenergic stimulation.
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central hypothyroidism models. As pointed out, an increase
in ICa-L reportedly due to thyroid hormone deficiency may
contribute to EAD triggering during b-adrenergic stimulation
in individuals with either type of hypothyroidism.
From a clinical perspective, several independent studies
proposed that elevated serum TSH levels play an essential
causal role in the QT prolongation and dispersion (QTd) in
patients with overt hypothyroidism. These abnormalities re-
vert after hormone replacement and normalization of TSH
levels (4,5,8). Here, based on the observations of the direct
effect of TSH on the K+ currents, a mechanistic explanation is
proposed for the TSH-dependent electrocardiographic alter-
ations and its possible contribution to enhanced susceptibility
to cardiac arrhythmias. These results, together with the re-
cently published association between high normal TSH levels
and increased risk of mortality, further contribute to an-
swering the question of whether serum TSH reference ranges
should be reexamined (1,2,39,40).
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